MedTrace Logo

Genomic Changes in Childhood Acute Lymphoblastic Leukemia

NCT01089907 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2010-03-19

No results posted yet for this study

Summary

To study the genomics with cell cycle and lymphocyte differentiation in disease, remission and relapse of childhood acute lymphoblastic leukemia. Then correlate these data with age, white cell count, cytogenetic changes, response to the chemotherapy and prognosis.

Conditions

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Dong-Tsamn Lin, M.D. · National Taiwan University Hospital,Taipei,Taiwan

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2013-01-31
Completion
2013-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01089907 on ClinicalTrials.gov